Habitual exercise and arterial aging
Aging affects the function and structure of arteries and increases the risk of cardiovascular
diseases (CVD). In healthy sedentary adults, aging is associated with increased stiffness …
diseases (CVD). In healthy sedentary adults, aging is associated with increased stiffness …
Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes
R Krysiak, B Okopień, ZS Herman - Drugs, 2003 - Springer
Recent large clinical trials have demonstrated that HMG-CoA reductase inhibitors, or statins,
markedly reduce morbidity and mortality when used in the primary and secondary …
markedly reduce morbidity and mortality when used in the primary and secondary …
The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty
G Benoni, S Lethagen, H Fredin - Thrombosis research, 1997 - Elsevier
The aim of the present study was to investigate aspects of coagulation and fibrinolysis
during knee arthroplasties in order to find out 1. whether an increased fibrinolysis is …
during knee arthroplasties in order to find out 1. whether an increased fibrinolysis is …
Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans
DT Smith, GL Hoetzer, JJ Greiner… - The Journal of …, 2003 - Wiley Online Library
The capacity of the vascular endothelium locally to release tissue‐type plasminogen
activator (t‐PA) is critical for effective endogenous fibrinolysis. We determined the influence …
activator (t‐PA) is critical for effective endogenous fibrinolysis. We determined the influence …
[图书][B] Treatment of the postmenopausal woman: basic and clinical aspects
RA Lobo - 2007 - books.google.com
For anyone who treats postmenopausal women, this latest edition of Rogerio Lobo's classic
work combines the best from two well-known references: Menopause, and the second …
work combines the best from two well-known references: Menopause, and the second …
4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in …
CO Bang, HK Park, MY Ahn, HK Shin… - Cerebrovascular …, 2001 - karger.com
Background and Purpose: Decreased fibrinolytic capacity due to increased plasminogen
activator inhibitor-1 (PAI-1) activity and decreased tissue-type plasminogen activator (t-PA) …
activator inhibitor-1 (PAI-1) activity and decreased tissue-type plasminogen activator (t-PA) …
Functional magnetic stimulation: a new modality for enhancing systemic fibrinolysis
VWH Lin, A Perkash, H Liu, D Todd, I Hsiao… - Archives of Physical …, 1999 - Elsevier
Objective: To investigate whether functional magnetic stimulation (FMS) of the leg muscles
could enhance systemic fibrinolysis. Design: A within-subject analysis of systemic …
could enhance systemic fibrinolysis. Design: A within-subject analysis of systemic …
siRNA Silencing of FpVtg Induces Ovarian Cell Apoptosis in Redtail Prawn, Fenneropenaeus penicillatus
Inadequate gonadal maturation and poor spawning performance increasingly threaten the
sustainability of shrimp aquaculture. Unraveling the mechanisms regulating ovarian …
sustainability of shrimp aquaculture. Unraveling the mechanisms regulating ovarian …
A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary …
B Zöller, PG de Frutos… - Thrombosis and …, 1998 - thieme-connect.com
Reduced fibrinolytic capacity due to increased plasminogen activator inhibitor-1 (PAI-1)
activity in plasma is a common finding in patients with coronary heart disease or venous …
activity in plasma is a common finding in patients with coronary heart disease or venous …
Thrombosis and the pharmacology of antithrombotic agents
ST Haines, HI Bussey - Annals of Pharmacotherapy, 1995 - journals.sagepub.com
Objective: To provide an overview of the current state of knowledge regarding the
physiology of hemostasis, the pathophysiology of thrombosis, and the pharmacology of …
physiology of hemostasis, the pathophysiology of thrombosis, and the pharmacology of …